Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

NCT00808184 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: CPT-11, Raltegravir (Isentress®), Midazolam

Sponsor

National University Hospital, Singapore